Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07420101 · ClinicalTrials.gov registry record · NA
Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs
A NA study of Caregiver Anxiety and Caregiver Anxiety Related to Cancer Imaging, sponsored by Kimberley Roche.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT07420101: Recruiting NA study of Caregiver Anxiety and Caregiver Anxiety Related to Cancer Imaging, sponsored by Kimberley Roche.
NCT07420101 is a NA study of Caregiver Anxiety and Caregiver Anxiety Related to Cancer Imaging that is actively recruiting participants, run by Kimberley Roche. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07420101, a NA study of Caregiver Anxiety and Caregiver Anxiety Related to Cancer Imaging, is actively recruiting participants, sponsored by Kimberley Roche.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
"Scanxiety" is a term coined to describe anxiety related to imaging during cancer treatment and has not been robustly studied in pediatric oncology caregivers. Mindfulness-based Stress Reduction (MBSR) is a meditation-based program that offers a non-pharmacologic approach to managing stress. The main purposes of this study are two-fold: 1). to determine if scanxiety exists in the caregivers of pediatric oncology patients and 2.) if scanxiety is found, does the implementation of a mindfulness program help to improve caregiver anxiety related to imaging.
Primary Outcome
Used to determine if the caregivers of pediatric oncology patients experience scanxiety. This one-item instrument scale ranges from 1 (not anxious at all) to 5 (extremely anxious). The goal of this instrument is to grossly establish if Scanxiety is present in caregivers. If caregivers answer between 2 (A little anxious)-5 (Extremely anxious) it demonstrates levels of anxiety.
Conditions Studied
Interventions
- OTHER Mindful Module Caregiver Packet
Study Locations (1)
Connecticut
- Connecticut Children's Medical Center - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
What NCT07420101 shows while recruiting
NCT07420101 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Caregiver Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Mindful Module Caregiver Packet is the first listed.
NCT07420101 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT07420101 about?
NCT07420101 is a clinical study titled "Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs". "Scanxiety" is a term coined to describe anxiety related to imaging during cancer treatment and has not been robustly studied in pediatric oncology caregivers. Mindfulness-based Stress Reduction (MBSR) is a meditation-based program that offers a non-pharmacologic approach to managing stress. The mai...
What is the current status of trial NCT07420101?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2026-02-01. Estimated completion is 2027-02-01.
What conditions does trial NCT07420101 study?
This clinical trial studies the following conditions: Caregiver Anxiety, Caregiver Anxiety Related to Cancer Imaging, Pediatric Oncology.
What interventions are being tested in trial NCT07420101?
The interventions under investigation include: Mindful Module Caregiver Packet (OTHER).
Who is sponsoring clinical trial NCT07420101?
This trial is sponsored by Kimberley Roche, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07420101 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07420101's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI